Autoimmune Diseases

Multiple Sclerosis


Publishing date
01 Mar 2011
Status
Published
Submission deadline
01 Sep 2010

1Department of Clinical Neurology, University of Oxford, Oxford, UK

2Department of Medical Genetics, University of Calgary, Calgary, AB, Canada

3Department of Neuroimmunology, Blizard Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, UK

4Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan


Multiple Sclerosis

Description

Multiple sclerosis (MS) is the commonest disease of the central nervous system (CNS) to cause permanent disability in young adults. Based on strong circumstantial evidence, MS is considered to be an organ-specific autoimmune disorder, but the exact cause is as yet unknown. It appears that the disease develops in a genetically susceptible population as a result of environmental exposures.

The incidence of MS has been documented to be increasing across the globe. The focus of this issue therefore will be on studies with a goal of further understanding the aetiology of the disease. Genetic, immunological, and epidemiological investigations are welcomed to help to elucidate the processes underlying MS causation. We are particularly interested in studies investigating:

  • The genetics/epigenetics of MS
  • The immunology of MS
  • The role of Epstein-Barr virus in MS
  • Vitamin D and its relationship to MS
  • Smoking and its relationship to MS
  • The use of new technologies/methods to understand MS pathogenesis, for example, whole genome sequencing, proteomics, and so forth

This list is not exhaustive, and other submissions fitting in with our main theme are welcome. We are also interested in receiving reviews covering any of the topics listed above.

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ad/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:

Autoimmune Diseases
 Journal metrics
See full report
Acceptance rate-
Submission to final decision-
Acceptance to publication-
CiteScore4.600
Journal Citation Indicator0.400
Impact Factor4.0
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.